个性化医疗终于要到来了吗？
Is personalized medicine finally arriving?
作者信息
Allison Malorye
出版信息
Nat Biotechnol. 2008 May;26(5):509-17. doi: 10.1038/nbt0508-509.
PMID:18464779
Abstract
It's no gold rush, but dozens of players are emerging in personalized medicine, with biotechs, big and small, leading the way. Some big pharma companies and even payers remain skeptical, but economics aside, the real winners will be patients.
摘要
这并非淘金热，但数十家企业正在涉足个性化医疗领域，其中大小生物科技公司引领潮流。一些大型制药公司甚至付款方仍持怀疑态度，但抛开经济因素不谈，真正的赢家将是患者。
Zotero 插件